DHSC: OHID: Human Papillomavirus (HPV) Screening In Vaccinated Populations

Provision of services to develop a cost-effective model to determine whether cervical cancer screening is clinically and cost effective in vaccinated populations in the UK. This model will project and compare the health benefits, harms, and costs associated with a range of strategies for HPV screening in vaccinated populations. Contract Project Reference: C162381 Contract term: 18 months with the option to extend for up to further 12 months Estimated contract value (including extensions): £278,990.00 (excluding of VAT); £334,788 (including VAT)

Additional information: The Authority considers the award of the contracts without prior publication of a contract notice is permitted by Regulation 32(2)(a) of the Public Contracts Regulations 2015 on the basis that no compliant tenders were received in the response to a competitive procedure published on 21/03/2022.

Provision of services to develop a cost-effective model to determine whether cervical cancer screening is clinically and cost effective in vaccinated populations in the UK. This model will project and compare the health benefits, harms, and costs associated with a range of strategies for HPV screening in vaccinated populations.

Contract Project Reference: C162381

Contract term: 18 months with the option to extend for up to further 12 months

Estimated contract value (including extensions): £278,990.00 (excluding of VAT); £334,788 (including VAT)